Fused heteroaryl carboxylic acids of formula (I): wherein R1, Ar, A, Y, HET, Q, and T are as defined in the specification; pharmaceutical compositions containing effective amounts of said compounds or their salts are useful for treating PPAR related disorders, such as diabetes, dyslipidemia, obesity and inflammatory disorders.
式(I)的融合杂
环羧酸:其中R1、Ar、A、Y、HET、Q和T如规范中定义;含有所述化合物或其盐的有效量的药物组合物对于治疗
PPAR相关疾病,如糖尿病、血脂异常、肥胖和炎症性疾病是有用的。